Figure 6.
(A) Plasma concentration–time curves of Cur suspension and PCur after oral administration at the dose of 50 mg/kg Cur (n = 6); (B) HPLC analysis: (1) Cur (5 μg/mL), (2) PCur (100 μg/mL), (3) intestinal perfusate from mice receiving PCur, (4) PEG, (5) blank intestinal perfusate from mice receiving PBS; (C) quantitative assay of Cur in mucous and muscular layers from different intestinal segments, *p < 0.05 versus other groups.